Secondary Logo

Journal Logo

February/March 2015 - Volume 38 - Issue 2
pp: 41-84

Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy

Odegard, Jared M.; Kelley-Clarke, Brenna; Tareen, Semih U.; More

Journal of Immunotherapy. 38(2):41-53, February/March 2015.

A Phase I Clinical Trial of CD1c (BDCA-1)+ Dendritic Cells Pulsed With HLA-A*0201 Peptides for Immunotherapy of Metastatic Hormone Refractory Prostate Cancer

Prue, Rebecca L.; Vari, Frank; Radford, Kristen J.; More

Journal of Immunotherapy. 38(2):71-76, February/March 2015.